Indwelling Stent Discoloration Project

Sponsor
University of British Columbia (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02007980
Collaborator
Vancouver General Hospital (Other)
70
1
117.9
0.6

Study Details

Study Description

Brief Summary

The aim of this study is to identify the root cause for the significant discolouration of Boston Scientific Percuflex based stents.

Detailed Description

The aim of this study is to identify the root cause for the significant discolouration of Boston Scientific Percuflex based stents observed in some patients, particularly those from Japan. We will also test and compare them to stents from Canadian patients. Furthermore, we will determine whether the discolouration promotes bacterial adhesion and/or encrustation of the stent.

Study Design

Study Type:
Observational
Anticipated Enrollment :
70 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Examining the Underlying Factors That Cause Ureteral Stent Discoloration in Japanese and Canadian Ureteral Stents
Study Start Date :
Dec 1, 2013
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Sep 29, 2023

Arms and Interventions

Arm Intervention/Treatment
Patients with indwelling ureteral stent

Patients with existing indwelling ureteral stent, no additional treatment

Outcome Measures

Primary Outcome Measures

  1. stent encrustation [at stent removal]

    Conditioning film components and encrustation

Secondary Outcome Measures

  1. characterize the components that discolour the Percuflex material [bench top testing of stents]

  2. Bacterial Adhesion, Colonization, and Biofilm formation [at 4, 24, and 48 hours post stent removal]

    Stent pieces from the stent that has been in the patient will be exposed to bacteria and artificial urine to mimic ureter environment in order to find information on: bacterial adhesion, colonization and biofilm formation

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patient is at least 19 years of age (Vancouver, British Columbia, Canada - for Japan different age limit as applicable)

  • Patient has indwelling ureteral stent

Exclusion Criteria:
  • Pregnancy

  • Positive Urine Culture

  • Active cancer

  • Recurrent urinary infections

  • Gross hematuria

  • Inability to provide informed consent

  • Physician/Surgeon refuses to enter patient into study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vancouver General Hospital Vancouver British Columbia Canada

Sponsors and Collaborators

  • University of British Columbia
  • Vancouver General Hospital

Investigators

  • Principal Investigator: Ben Chew, MD, UBC/VGH

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ben Chew, MD, Associate Professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT02007980
Other Study ID Numbers:
  • H13-02715
First Posted:
Dec 11, 2013
Last Update Posted:
May 17, 2022
Last Verified:
May 1, 2022
Keywords provided by Ben Chew, MD, Associate Professor, University of British Columbia
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 17, 2022